ICTI’s other pipeline includes PDE inhibitor for Parkinson’s and cancer immunotherapy and ITI-333 for opioid use disorder, pain and mood disorders. It also utilizes CNSProfile, a technology platform ...

A team of researchers at The Keck School of Medicine of USC have received a $3.4 million federal grant to advance research on ...

Community pharmacy owners are having to take out bank loans, remortgage houses and dip into their own pockets to make up a ...

Stock analysts at Maxim Group started coverage on shares of Alterity Therapeutics (NASDAQ:ATHE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a ...

Alzheimer’s drugs should be prescribed like statins to stave off dementia, one of Britain’s leading neuroscientists has said.

The NHS has paid out tens of thousands to a man who developed an “uncontrollable” gambling problem after he was given a common Parkinson’s drug, The Independent can reveal Philip Stevens, a 66 year ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

According to NHS warnings, Ropinirole can cause patients to start binge eating, gambling and shopping uncontrollably, or have ...

A Penn Medicine-led consortium of radiology and chemistry researchers across the United States will advance imaging of ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

The North Chicago-based drugmaker said it's received positive topline results in a Phase 3 trial of its investigational ...